MedTrace Logo

Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux

NCT06898268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2025-03-27

No results posted yet for this study

Summary

This study aimed to fill the gaps by comparing the efficacy and safety of ondansetron versus metoclopramide for the control of gastroesophageal reflux disorder in children 1-12 months of age, presenting at the outdoor department of Allama Iqbal Teaching Hospital, Dera Ghazi Khan.

Conditions

  • Gastroesophageal Reflux Disorder

Interventions

DRUG

Metoclopramide

Patients were prescribed metoclopramide twice a day for one week.

DRUG

Ondansetron

Patients were put on oral ondansetron in BD doses for one week.

Sponsors & Collaborators

  • Muhammad Aamir Latif

    lead OTHER

Principal Investigators

  • Irum Jabeen, FCPS · Allama Iqbal Teaching Hospital, Dera Ghazi Khan, Pakistan

  • Asma Akbar, FCPS · Allama Iqbal Teaching Hospital, Dera Ghazi Khan, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06898268 on ClinicalTrials.gov